The recruiting you are referencing is the large pivotal trial, which can only happen after the small early feasibility trial is completed and we haven't started the EFS yet. The EFS should commence soon though, so I'd say the announcement for that is "imminent".
- Forums
- ASX - By Stock
- $66.32 price target - Evolution Capital initiation of coverage
AVR
anteris technologies global corp.
Add to My Watchlist
0.49%
!
$6.12

The recruiting you are referencing is the large pivotal trial,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.12 |
Change
-0.030(0.49%) |
Mkt cap ! $94.85M |
Open | High | Low | Value | Volume |
$6.21 | $6.21 | $6.00 | $16.53K | 2.704K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $6.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 240 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 6.010 |
2 | 1624 | 6.000 |
1 | 25 | 5.850 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 240 | 1 |
6.180 | 50 | 1 |
6.190 | 1000 | 1 |
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
Last trade - 15.46pm 25/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online